- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06075303
Dynamic Assessment of Phonological Disorders
October 3, 2023 updated by: University of Montana
Dynamic Assessment of Phonological Disorders: Part 1 Assessment & Part 2 Treatment
The goal of this clinical trial is to learn about (1) how speech skills can be measured and how various tests give speech therapists different types of information for children with speech sound disorder, and (2) whether changes occur in the amount of help children need when they work on easier sounds or harder sounds during treatment.
The main questions this study aims to answer are: (1) what does one type of test (dynamic assessment) tell us about speech skills compared to another type of test (static assessment), and (2) does practice of easier or harder sounds show differences in progress.
Participants will complete 16 sessions of speech treatment called "modified cycles treatment", and will complete several speech and language tests before, during, and after treatment by pointing to pictures, and saying sounds, words, and sentences.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Glaspey Dynamic Assessment of Phonology (GDAP) (Glaspey, 2006; Glaspey & Stoel-Gammon, 2007) was initially developed because children with speech-sound delays make very slow progress in speech therapy and it is difficult to document change in short periods of time using traditional methods of assessment.
The traditional methods rely on picture-naming tasks and the child is not given any assistance in speech productions.
The lack of assistance often results in a floor effect in the documentation of change and progress.
Without good documentation of change, speech-language pathologists are left uncertain about the efficacy of the treatment that they are administering.
The GDAP is unique because it assesses change based on dynamic assessment; children are systematically given assistance in the production of speech sounds.
When administering the GDAP, clinicians rate each sound on a 15-point ordinal scale that represents the number of cues and assistance that could be used to assist the child in sound production.
Progress is documented as children need less support over time and their scores decrease.
This study compares the GDAP with a traditional single-word measure.
This study also has an extension to use the GDAP to select easier or harder targets during treatment, and monitor children's progress across measures over 8 weeks of modified cycles treatment.
The treatment will include 16 sessions of therapy with two 50-minute sessions per week.
The treatment approach that will be used is called "Cycles" and involves practicing a different speech sound each week (Rudolf & Wendt, 2014).
The sounds that are practiced will be individualized to each child's needs, with harder sounds taught during four of the weeks and easier sounds taught during four of the weeks.
The order will be counter-balanced across participants.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- monolingual English speakers;
- scores in the mild to profound range for phonological disorder based on the Hodson Assessment of Phonological Patterns (Hodson, 2004);
- scores above 9th percentile on receptive language and cognitive abilities based on measures from the Preschool Language Scale-4 (PLS-4) (Zimmerman, Steiner, & Pond, 2002) and the Peabody Picture Vocabulary Test (PPVT) (Dunn & Dunn, 1997);
- perform adequately on a structural-functional examination adapted from the Oral and Speech Motor Control Protocol (Robbins & Klee, 1987) and Motor Speech Examination (Strand & McCauley, 1999);
- exhibit voice and fluency skills within normal limits,
- pass a hearing screening adequate for understanding speech.
Exclusion Criteria:
- will not exhibit the prime characteristics of developmental apraxia of speech and/or dysarthria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Easier Targets
All participants will participate in a modified Cycles approach where speech targets are worked on for a short period of time and switched within a cycle.
During the Easier Targets arm, children will work on target sounds that are "easier" based on their pre-treatment scores of 8, 9, 10, or 11 on the Glaspey Dynamic Assessment of Phonology.
Children will complete 8 sessions in this arm that are each 50-minutes long and occur two times per week with each target addressed for 2 sessions.
|
|
|
Experimental: Harder Targets
All participants will participate in a modified Cycles approach where speech targets are worked on for a short period of time and switched within a cycle.
During the Harder Targets arm, children will work on target sounds that are "harder" based on their pre-treatment scores of 15, 14, 13, or 12 on the Glaspey Dynamic Assessment of Phonology.
Children will complete 8 sessions in this arm that are each 50-minutes long and occur two times per week with each target addressed for 2 sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glaspey Dynamic Assessment of Phonology (GDAP)
Time Frame: Prior to treatment, after four weeks of treatment, and again after eight weeks.
|
The GDAP is an evaluation of speech sounds when given help while talking about pictures. The child is asked to say all sounds by themselves, in words, or in sentences. The child is given verbal modeling and instructions to help him/her say the sounds correctly to the highest level possible (i.e. sentences without any model). |
Prior to treatment, after four weeks of treatment, and again after eight weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Static Assessment of Single Words
Time Frame: Prior to treatment, after four weeks of treatment, and again after eight weeks.
|
Evaluation of speech sounds in words using pictures.
The child will be shown 50-80 picture cards and asked to say the pictures.
There pictures feature sounds that may be in error by the child.
|
Prior to treatment, after four weeks of treatment, and again after eight weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amy M Glaspey, Ph.D., University of Montana
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 4, 2011
Primary Completion (Actual)
May 11, 2012
Study Completion (Actual)
May 11, 2012
Study Registration Dates
First Submitted
October 3, 2023
First Submitted That Met QC Criteria
October 3, 2023
First Posted (Estimated)
October 10, 2023
Study Record Updates
Last Update Posted (Estimated)
October 10, 2023
Last Update Submitted That Met QC Criteria
October 3, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 186-11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.